As a massive public inquiry in the UK opens to the public, we asked key people what questions they have.
A massive inquiry to understand the UK's response to, and the impact of, the Covid-19 pandemic, throws its doors open to the public on Tuesday, with the first evidence session. Not one of us was left untouched by the effects of the pandemic, and we all have questions. I asked a range of people who were at the eye of the Covid storm what one question each of them most wants answered.
Femi is one of nearly 250,000 people killed by Covid in the UK - and Lobby, part of the Covid Bereaved Families for Justice campaign group, wants to ensure these deaths were "not in vain".A crucial part of that will be looking at why people belonging to ethnic minorities were at such greater risk. There is no "physiological reason" why they had worse outcomes, Lobby says.
One senior public health official, who played a key role in the pandemic and is due to give evidence, says it is hard to see how the first lockdown could have been avoided once the virus was here. Put simply: "We did not know what we were dealing with." But after the first wave was over and scientists understood more, the government should not have been so quick to reimpose restrictions.
UK children spent six months remote learning, with hairdressers and pubs opening before schools in the first lockdown - a decision repeated for hairdressers in Scotland after the second UK-wide lockdown, in early 2021. "The UK and much of Europe and North America was largely underprepared for a pandemic of this magnitude - and that cost us."
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Investigating the alveolar type II reparative response in COVID-19 pneumoniaInvestigating the alveolar type II reparative response in COVID-19 pneumonia JIDJournal UMNews covid COVID19 SARSCoV2 pneumonia covidpneumonia COVIDpneumonia
Read more »
SARS-CoV-2 hijacks body's metabolism to amplify COVID-19 severityIn a review article published in the journal Signal Transduction and Targeted Therapy, scientists have discussed host metabolic alteration triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its effect on disease severity.
Read more »
Diabetes drug could reduce chances of getting long COVID, study suggestsThe US study showed that taking Metformin within three days of testing positive helped reduce chances of developing long COVID.
Read more »
MIS-C in children: A distinct autoimmune response to COVID-19 unveiledThe study reveals that MIS-C patients, post SARS-CoV-2 infection, develop a unique immune response against the virus' N protein, indicating a cross-reactivity with the self-protein SNX8, which might link the infection to the ensuing inflammatory syndrome.
Read more »
COVID-19 mRNA Vaccines Are Safe for Kids as Young as Six Months, Study SaysNew research finds that getting multiple COVID-19 mRNA vaccines is safe for kids under 5.
Read more »
Common diabetes medication reduces risk of developing long Covid by 40%, scientists discoverThe US study is the first published randomised control trial to suggest medication taken during the acute phase of Covid may be able to reduce the risk of long Covid PMGallagher1 reports
Read more »